BridgeBio oncology unit may offer up to $500 million securities
BridgeBio Oncology Therapeutics Inc (BBOT) filed with the SEC to potentially offer up to $500 million in securities, according to TradingView News.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.